Avance
Avance is a globally renowned specialist in valuation in life sciences. Avance provides corporate finance services for investors, biotech companies, pharmaceutical companies and tech transfer offices around the globe. Its valuation software ri:val (TM) has become widely appreciated for valuation of complex deal structures and biotechnology companies. Avance understands itself also as a think tank and publishes articles, books, and reports on industry related topics.
Title ![]() | Date ![]() | Price ![]() |
|---|---|---|
| Success Rates in Biotech Going The Wrong Way | Mar 2009 | £885 |
call +44 (0) 20 7060 7474
or email us


previous












